SMITH, MOORE & CO. - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 817 filers reported holding GLAXOSMITHKLINE PLC in Q3 2020. The put-call ratio across all filers is 0.91 and the average weighting 0.2%.

Quarter-by-quarter ownership
SMITH, MOORE & CO. ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q2 2022$426,000
-7.6%
9,782
-7.6%
0.07%
+4.8%
Q1 2022$461,000
-5.5%
10,582
-4.3%
0.06%
-7.4%
Q4 2021$488,000
+21.4%
11,063
+5.1%
0.07%
+11.5%
Q3 2021$402,000
-4.5%
10,522
-0.4%
0.06%
-3.2%
Q2 2021$421,000
+28.4%
10,563
+15.0%
0.06%
+18.9%
Q1 2021$328,000
-2.7%
9,183
+0.3%
0.05%
-15.9%
Q4 2020$337,000
-23.1%
9,155
-21.3%
0.06%
-30.8%
Q3 2020$438,000
+11.7%
11,637
+21.0%
0.09%
+4.6%
Q2 2020$392,000
-3.7%
9,618
-10.4%
0.09%
-18.7%
Q1 2020$407,000
+13.4%
10,731
+40.3%
0.11%
+42.7%
Q4 2019$359,000
-17.3%
7,646
-24.8%
0.08%
-21.9%
Q3 2019$434,000
-4.8%
10,171
-10.7%
0.10%
-6.8%
Q2 2019$456,000
-4.2%
11,394
+0.0%
0.10%
-8.8%
Q1 2019$476,000
+24.0%
11,389
+13.4%
0.11%
+8.7%
Q4 2018$384,000
-24.3%
10,044
-20.4%
0.10%
-10.3%
Q3 2018$507,000
+2.2%
12,611
+2.5%
0.12%
-6.5%
Q2 2018$496,000
+25.9%
12,303
+21.9%
0.12%
+17.0%
Q1 2018$394,000
-10.9%
10,096
-18.9%
0.11%
-10.9%
Q4 2017$442,000
-9.1%
12,447
+3.9%
0.12%
-13.8%
Q3 2017$486,000
+20.0%
11,982
+27.5%
0.14%
+1.5%
Q2 2017$405,000
+4.4%
9,401
+2.2%
0.14%
-2.2%
Q1 2017$388,000
+12.8%
9,196
+3.0%
0.14%
+6.1%
Q4 2016$344,000
-8.0%
8,930
+3.0%
0.13%
-12.7%
Q3 2016$374,000
+1.9%
8,669
+2.4%
0.15%
-1.3%
Q2 2016$367,0008,4660.15%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q3 2020
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 100,000$3,680,00012.40%
Black Creek Investment Management Inc. 7,443,061$273,905,0008.54%
KAHN BROTHERS GROUP INC 1,281,924$47,174,803,0008.23%
Camber Capital Management LP 3,500,000$128,800,0004.52%
Eversept Partners, LP 946,581$35,196,5224.13%
EQUITY INVESTMENT CORP 2,321,164$85,419,0003.98%
Galibier Capital Management Ltd. 575,741$21,187,0003.66%
Keystone Financial Planning, Inc. 217,399$8,000,0003.32%
CLIFFORD CAPITAL PARTNERS LLC 217,817$8,016,0003.14%
CLARK ESTATES INC/NY 485,000$17,848,0002.52%
View complete list of GLAXOSMITHKLINE PLC shareholders